The U.S. Food and Drug Administration (FDA) has refused to consider Moderna’s application for a new flu vaccine, which utilizes Nobel Prize-winning mRNA technology, the company announced on Tuesday.
This decision signals heightened scrutiny of vaccines by the FDA under Health Secretary Robert F. Kennedy Jr., particularly those employing mRNA technology, which he has publicly criticized both before and since assuming his role.
